Showing results (541-550 of 603) with videos related to

Sort By:
Pageof 61
Journal for Immunotherapy of Cancer|April 5, 2024
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AMLVania Lo Presti, Angelo Meringa, Ester Dunnebach, et al.
Bone Marrow Transplantation|October 30, 2019
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplantAnne L Ryan, Ushma D Wadia, Peter Jacoby, et al.
British Journal of Cancer|April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofinMawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.
Pediatric Blood & Cancer|July 24, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALLMiguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, et al.
G3 (Bethesda, Md.)|August 25, 2019
Population Selection and Sequencing of Caenorhabditis elegans Wild Isolates Identifies a Region on Chromosome III Affecting Starvation ResistanceAmy K Webster, Anthony Hung, Brad T Moore, et al.
American Journal of Human Genetics|October 31, 2000
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotypeG A Bellus, E B Spector, P W Speiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
The AAPS Journal|August 24, 2017
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage FormsAndre Hermans, Andreas M Abend, Filippos Kesisoglou, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and CommercializationHaiyan Grady, David Elder, Gregory K Webster, et al.
Journal of Clinical Epidemiology|March 4, 2021
Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?Rebecca K Webster, Felicity Bishop, Gary S Collins, et al.
Pageof 61